p63: Molecular complexity in development and cancer

Carcinogenesis

Volumn 25, Issue 6, 2004, Pages 857-864

  Westfall, Matthew D ^a   Pietenpol, Jennifer A ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53; PROTEIN P63; RNA; TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; PHOSPHOPROTEIN; TP73L PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; AUTOSOMAL DOMINANT DISORDER; BASAL CELL; BIOCHEMISTRY; BREAST EPITHELIUM; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE; CELL NUCLEUS; CELL REGENERATION; DEVELOPMENTAL BIOLOGY; ECTODERM; EMBRYONIC STRUCTURES; ENDOTHELIUM CELL; GENETIC REGULATION; GENETIC VARIABILITY; HUMAN; MOLECULAR BIOLOGY; MOLECULAR MODEL; MOUTH MUCOSA; MYOEPITHELIUM; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; RNA SPLICING; SKIN EPITHELIUM; SQUAMOUS CELL CARCINOMA; STRESS; UROTHELIUM; ANIMAL; GENETICS; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

ANIMALS; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS; PHOSPHOPROTEINS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS;

EID: 3042813412     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh148     Document Type: Review

References (102)

1. Kaghad,M., Bonnet,H., Yang,A. et al. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90, 808-819.
2. Schmale,H. and Bamberger,C. (1997) A novel protein with strong homology to the tumor suppressor p53. Oncogene, 15, 1363-1367.
3. Yang,A., Kaghad,M., Wang,Y., Gillet,E., Fleming,M., Dotsch,V., Andrews,N., Caput,D. and McKeon,F. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing and dominant-negative activities. Mol. Cell., 2, 305316.
4. Augustin,M., Bamberger,C., Paul,D. and Schmale,H. (1998) Cloning and chromosomal mapping of the human p53-related KET gene to Chromosome 3q27 and its murine homolog Ket to mouse Chromosome 16. Mamm. Genome, 9, 899-902.
5. Trink,B., Okami,K., Wu,L., Sriuranpong,V., Jen,J. and Sidransky,D. (1998) A new human p53 homologue. Nature Med., 4, 747-748.
6. Osada,M., Ohba,M., Kawahara,C. et al. (1998) Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nature Med., 4, 839-843.
7. Chen,X. (1999) The p53 family: same response, different signals? Mol. Med. Today, 5, 387-392.
8. Schultz,J., Ponting,C.P., Hofmann,K. and Bork,P. (1997) SAM as a protein interaction domain involved in developmental regulation. Protein Sci., 6, 249-253.
9. Thanos,C.D. and Bowie,J.U. (1999) p53 family members p63 and p73 are SAM domain-containing proteins. Protein Sci., 8, 1708-1710.
10. Zhang,H., Xu,Q., Krajewski,S., Krajewska,M., Xie,Z., Fuess,S., Kitada,S., Pawlowski,K., Godzik,A. and Reed,J.C. (2000) BAR: an apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc. Natl Acad. Sci. USA, 97, 2597-602.
11. Kasten,M. and Giordano,A. (2001) Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity. Oncogene, 20, 1832-1838.
12. Baker,K.M., Wei,G., Schaffner,A.E. and Ostrowski,M.C. (2003) Ets-2 and components of mammalian SWI/SNF form a repressor complex that negatively regulates the BRCA1 promoter. J. Biol. Chem., 278, 17876-17884.
13. Serra-Pages,C., Kedersha,N.L., Fazikas,L., Medley,Q., Debant,A. and Streuli,M. (1995) The LAR transmembrane protein tyrosine phosphatase and a coiled-coil LAR-interacting protein co-localize at focal adhesions. EMBO J., 14, 2827-38.
14. Stein,E., Cerretti,D.P. and Daniel,T.O. (1996) Ligand activation of ELK receptor tyrosine kinase promotes its association with Grb10 and Grb2 in vascular endothelial cells. J. Biol. Chem., 271, 23588-23593.
15. Stein,E., Lane,A.A., Cerretti,D.P., Schoecklmann,H.O., Schroff,A.D., Van Etten,R.L. and Daniel,T.O. (1998) Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment and assembly responses. Genes Dev., 12, 667-678.
16. Hock,B., Bohme,B., Karn,T., Yamamoto,T., Kaibuchi,K., Holtrich,U., Holland,S., Pawson,T., Rubsamen-Waigmann,H. and Strebhardt,K. (1998) PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor. Proc. Natl Acad. Sci. USA, 95, 9779-9784.
17. Chakrabarti,S.R., Sood,R., Ganguly,S., Bohlander,S., Shen,Z. and Nucifora,G. (1999) Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9. Proc. Natl Acad. Sci. USA, 96, 7467-7472.
18. Aviv,T., Lin,Z., Lau,S., Rendl,L.M., Sicheri,F. and Smibert,C.A. (2003) The RNA-binding SAM domain of Smaug defines a new family of post-transcriptional regulators. Nat. Struct. Biol., 10, 614-621.
19. Green,J.B., Gardner,C.D., Wharton,R.P. and Aggarwal,A.K. (2003) RNA recognition via the SAM domain of Smaug. Mol. Cell., 11, 1537-1548.
20. Celli,J., Duijf,P., Hamel,B. et al. (1999) Heterozygous germline muations in the p53 homolog p63 are the cause of EEC syndrome. Cell, 99, 143-153.
21. Dietz,S., Rother,K., Bamberger,C., Schmale,H., Mossner,J. and Engeland,K. (2002) Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73. FEBS Lett., 525, 93-99.
22. Westfall,M.D., Mays,D.J., Sniezek,J.C. and Pietenpol,J.A. (2003) The ΔNp63α phosphoprotein binds the p21 and 14-3-3σ promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol. Cell Biol., 23, 2264-2276.
23. Zeng,S.X., Dai,M.S., Keller,D.M. and Lu,H. (2002) SSRP1 functions as a co-activator of the transcriptional activator p63. EMBO J., 21, 5487-5497.
24. Bergamaschi,D., Samuels,Y., Jin,B., Duraisingham,S., Crook,T. and Lu,X. (2004) ASPP1 and ASPP2: common activators of p53 family members. Mol. Cell Biol., 24, 1341-1350.
25. Ghioni,P., Bolognese,F., Duijf,P.H., Van Bokhoven,H., Mantovani,R. and Guerrini,L. (2002) Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains. Mol. Cell Biol., 22, 8659-8668.
26. Serber,Z., Lai,H.C., Yang,A. et al. (2002) A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism. Mol. Cell Biol., 22, 8601-8611.
27. Flores,E.R., Tsai,K.Y., Crowley,D., Sengupta,S., Yang,A., McKeon,F. and Jacks,T. (2002) p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature, 416, 560-564.
28. Ishida,S., Yamashita,T., Nakaya,U. and Tokino,T. (2000) Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells. Jpn. J. Cancer Res., 91, 174-180.
29. Dohn,M., Zhang,S.Z. and Chen,X.B. (2001) p63α and DeltaNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene, 20, 3193-3205.
30. Liefer,K.M., Koster,M.I., Wang,X.J., Yang,A., McKeon,F. and Roop,D.R. (2000) Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. Cancer Res., 60, 4016-4020.
31. Ziegler,A., Jonason,A.S., Leffell,D.J., Simon,J.A., Sharma,H.W., Kimmelman,J., Remington,L., Jacks,T. and Brash,D.E. (1994) Sunburn and p53 in the onset of skin cancer. Nature, 372, 773-776.
32. Donehower,L.A., Harvey,M., Slagle,B.L., McArthur,M.J., Montgomery,C.A.,Jr, Butel,J.S. and Bradley,A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
33. Mills,A.A., Zheng,B.H., Wang,X.J., Vogel,H., Roop,D.R. and Bradley,A. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature, 398, 708-713.
34. Yang,A., Schweitzer,R., Sun,D. et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature, 398, 714-718.
35. Lee,H. and Kimelman,D. (2002) A dominant-negative form of p63 is required for epidermal proliferation in zebrafish. Dev. Cell, 2, 607-616.
36. Bakkers,J., Hild,M., Kramer,C., Furutani-Seiki,M. and Hammerschmidt,M. (2002) Zebrafish ΔNp63 is a direct target of Bmp signaling and encodes a transcriptional repressor blocking neural specification in the ventral ectoderm. Dev. Cell, 2, 617-627.
37. Tickle,C. (1995) Vertebrate limb development. Curr. Opin. Genet. Dev., 5, 478-484.
38. Johnson,R.L. and Tabin,C.J. (1997) Molecular models for vertebrate limb development. Cell, 90, 979-990.
39. Hogan,B.L. (1996) Bone morphogenetic proteins in development. Curr. Opin. Genet. Dev., 6, 432-438.
40. Mullins,M.C. (1999) Embryonic axis formation in the zebrafish. Methods Cell. Biol., 59, 159-178.
41. Hemmati-Brivanlou,A. and Melton,D. (1997) Vertebrate embryonic cells will become nerve cells unless told otherwise. Cell, 88, 13-17.
42. Bamberger,C., Pollet,D. and Schmale,H. (2002) Retinoic acid inhibits downregulation of ΔNp63α expression during terminal differentiation of human primary keratinocytes. J. Invest. Dermatol., 118, 133-138.
43. Parsa,R., Yang,A., McKeon,F. and Green,H. (1999) Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J. Invest. Dermatol., 113, 1099-1105.
44. Di Como,C.J., Urist,M.J., Babayan,I., Drobnjak,M., Hedvat,C.V., Teruya-Feldstein,J., Pohar,K., Hoos,A. and Cordon-Cardo,C. (2002) p63 expression profiles in human normal and tumor tissues. Clin. Cancer Res., 8, 494-501.
45. Fuchs,E. and Raghavan,S. (2002) Getting under the skin of epidermal morphogenesis. Nat. Rev. Genet., 3, 199-209.
46. Francis-West,P., Ladher,R., Barlow,A. and Graveson,A. (1998) Signalling interactions during facial development. Mech. Dev., 75, 3-28.
47. Koster,M.I., Kim,S., Mills,A.A., DeMayo,F.J. and Roop,D.R. (2004) p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev., 18, 126-131.
48. Fisher,G.J., Esmann,J., Griffiths,C.E. et al. (1991) Cellular, immunologic and biochemical characterization of topical retinoic acid-treated human skin. J. Invest. Dermatol., 96, 699-707.
49. Pellegrini,G., Dellambra,E., Golisano,O., Martinelli,E., Fantozzi,I., Bondanza,S., Ponzin,D., McKeon,F. and De Luca,M. (2001) p63 identifies keratinocyte stem cells. Proc. Natl Acad. Sci. USA, 98, 3156-3161.
50. Barrandon,Y. and Green,H. (1987) Three clonal types of keratinocyte with different capacities for multiplication. Proc. Natl Acad. Sci. USA, 84, 2302-2306.
51. Sasaki,Y., Ishida,S., Morimoto,I., Yamashita,T., Kojima,T., Kihara,C., Tanaka,T., Imai,K., Nakamura,Y. and Tokino,T. (2002) The p53 family member genes are involved in the Notch signal pathway. J. Biol. Chem., 277, 719-724.
52. Struhl,G. and Adachi,A. (1998) Nuclear access and action of notch in vivo. Cell, 93, 649-660.
53. Schroeter,E.H., Kisslinger,J.A. and Kopan,R. (1998) Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature, 393, 382-386.
54. Nishi,H., Senoo,M., Nishi,K.H., Murphy,B., Rikiyama,T., Matsumura,Y., Habu,S. and Johnson,A.C. (2001) p53 homologue p63 represses epidermal growth factor receptor expression. J. Biol. Chem., 276, 41717-41724.
55. Dohn,M., Jiang,J. and Chen,X. (2001) Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis. Oncogene, 20, 6503-6515.
56. Lindberg,R.A. and Hunter,T. (1990) cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases. Mol. Cell Biol., 10, 6316-6324.
57. Miao,H., Wei,B.R., Peehl,D.M., Li,Q., Alexandrou,T., Schelling,J.R., Rhim,J.S., Sedor,J.R., Burnett,E. and Wang,B. (2001) Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat. Cell Biol., 3, 527-530.
58. Zantek,N.D., Azimi,M., Fedor-Chaiken,M., Wang,B., Brackenbury,R. and Kinch,M.S. (1999) E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ., 10, 629-638.
59. McGrath,J.A., Duijf,P.H., Doetsch,V. et al. (2001) Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Hum. Mol. Genet., 10, 221-229.
60. Duijf,P.H., Vanmolkot,K.R., Propping,P., Friedl,W., Krieger,E., McKeon,F., Dotsch,V., Brunner,H.G. and van Bokhoven,H. (2002) Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63. Hum. Mol. Genet., 11, 799-804.
61. van Bokhoven,H., Hamel,B.C., Bamshad,M. et al. (2001) p63 Gene mutations in eec syndrome, limb-mammary syndrome and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am. J. Hum. Genet., 69, 481-492.
62. Ianakiev,P., Kilpatrick,M.W., Toudjarska,I., Basel,D., Beighton,P. and Tsipouras,P. (2000) Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. Am. J. Hum. Genet., 67, 59-66.
63. Chi,S.W., Ayed,A. and Arrowsmith,C.H. (1999) Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain. EMBO J., 18, 4438-4445.
64. Fomenkov,A., Huang,Y.P., Topaloglu,O., Brechman,A., Osada,M., Fomenkova,T., Yuriditsky,E., Trink,B., Sidransky,D. and Ratovitski,E. (2003) p63α mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome. J. Biol. Chem., 278, 23906-23914.
65. Crook,T., Nicholls,J.M., Brooks,L., O'Nions,J. and Allday,M.J. (2000) High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene, 19, 3439-3444.
66. Hibi,K., Trink,B., Patturajan,M., Westra,W.H., Caballero,O.L., Hill,D.E., Ratovitski,E.A., Jen,J. and Sidransky,D. (2000) AIS is an oncogene amplified in squamous cell carcinoma. Proc. Natl Acad. Sci. USA, 97, 5462-5467.
67. Park,B.J., Lee,S.J., Kim,J.I., Lee,C.H., Chang,S.G., Park,J.H. and Chi,S.G. (2000) Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res., 60, 3370-3374.
68. Yamaguchi,K., Wu,L., Caballero,O. et al. (2000) Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma. Int. J. Cancer, 86, 684-689.
69. Massion,P.P., Taflan,P.M., Jamshedur Rahman,S.M. et al. (2003) Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res., 63, 7113-7121.
70. Hagiwara,K., McMenamin,M.G., Miura,K. and Harris,C.C. (1999) Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers. Cancer Res., 59, 4165-4169.
71. Heselmeyer,K., Schrock,E., du Manoir,S., Blegen,H., Shah,K., Steinbeck,R., Auer,G. and Ried,T. (1996) Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc. Natl Acad. Sci. USA, 93, 479-484.
72. Howley,P.M., Scheffner,M., Huibregtse,J. and Münger,K. (1991) Oncoproteins encoded by the cancer-associated human papillomaviruses target the products of the retinoblastoma and p53 tumor suppressor genes. Cold Spring Harbor Symp. Quant. Biol., 56, 149-155.
73. Wang,T.Y., Chen,B.F., Yang,Y.C. et al. (2001) Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases. Hum. Pathol., 32, 479-486.
74. Reis-Filho,J.S., Simpson,P.T., Martins,A., Preto,A., Gartner,F. and Schmitt,F.C. (2003) Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virch. Arch., 443, 122-132.
75. Massion,P.P., Kuo,W.L., Stokoe,D. et al. (2002) Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Cancer Res., 62, 3636-3640.
76. Barbieri,C.E., Barton,C.E. and Pietenpol,J.A. (2003) ΔNp63α Expression is regulated by the phosphoinositide 3-kinase pathway. J. Biol. Chem., 278, 51408-51414.
77. Senoo,M., Matsumura,Y. and Habu,S. (2002) TAp63γ (p51A) and ΔNp63α (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression. Oncogene, 21, 2455-2465.
78. Patturajan,M., Nomoto,S., Sommer,M. et al. (2002) ΔNp63 induces beta-catenin nuclear accumulation and signaling. Cancer Cell., 1, 369-379.
79. Hildesheim,J., Belova,G.I., Tyner,S.D., Zhou,X., Vardanian,L. and Fornace,A.J. (2004) Gadd45α regulates matrix metalloproteinases by suppressing ΔNp63α and beta-catenin via p38 MAP kinase and APC complex activation. Oncogene, 23, 1823-1837.
80. Koga,F., Kawakami,S., Fujii,Y., Saito,K., Ohtsuka,Y., Iwai,A., Ando,N., Takizawa,T., Kageyama,Y. and Kihara,K. (2003) Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin. Cancer Res., 9, 5501-5507.
81. Urist,M.J., Di Como,C.J., Lu,M.L., Charytonowicz,E., Verbel,D., Crum,C.P., Ince,T.A., McKeon,F.D. and Cordon-Cardo,C. (2002) Loss of p63 expression is associated with tumor progression in bladder cancer. Am. J. Pathol., 161, 1199-1206.
82. Wang,X., Mori,I., Tang,W., Nakamura,M., Nakamura,Y., Sato,M., Sakuri,T. and Kakudo,K. (2002) p63 Expression in normal, hyperplastic and malignant breast tissues. Breast Cancer, 9, 216-219.
83. Barbareschi,M., Pecciarini,L., Cangi,M.G., Macri,E., Rizzo,A., Viale,G. and Doglioni,C. (2001) p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am. J. Surg. Pathol., 25, 1054-1060.
84. Ribeiro-Silva,A., Zambelli Ramalho,L.N., Britto Garcia,S. and Zucoloto,S.(2003) The relationship between p63 and p53 expression in normal and neoplastic breast tissue. Arch. Pathol. Lab. Med., 127, 336-340.
85. Reis-Filho,J.S. and Schmitt,F.C. (2003) p63 expression in sarcomatoid/metaplastic carcinomas of the breast. Histopathology, 42, 94-95.
86. Nishi,H., Isaka,K., Sagawa,Y., Usuda,S., Fujito,A., Ito,H., Senoo,M., Kato,H. and Takayama,M. (1999) Mutation and transcription analyses of the p63 gene in cervical carcinoma. Int. J. Oncol., 15, 1149-1153.
87. Cviko,A., Briem,B., Granter,S.R. et al. (2000) Adenoid basal carcinomas of the cervix: a unique morphological evolution with cell cycle correlates. Hum. Pathol., 31, 740-744.
88. Quade,B.J., Yang,A., Wang,Y. et al. (2001) Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol. Oncol., 80, 24-29.
89. Cho,N.H., Kim,Y.B., Park,T.K., Kim,G.E., Park,K. and Song,K.J. (2003) p63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma. Gynecol. Oncol., 91, 346-353.
90. Choi,H.R., Batsakis,J.G., Zhan,F., Sturgis,E., Luna,M.A. and El-Naggar,A.K. (2002) Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum. Pathol., 33, 158-164.
91. Hu,H., Xia,S.H., Li,A.D. et al. (2002) Elevated expression of p63 protein in human esophageal squamous cell carcinomas. Int. J. Cancer, 102, 580-583.
92. Nylander,K., Coates,P.J. and Hall,P.A. (2000) Characterization of the expression pattern of p63α and Δ Np63α in benign and malignant oral epithelial lesions. Int. J. Cancer, 87, 368-372.
93. Weber,A., Bellmann,U., Bootz,F., Wittekind,C. and Tannapfel,A. (2002) Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck. Int. J. Cancer, 99, 22-28.
94. Geddert,H., Kiel,S., Heep,H.J., Gabbert,H.E. and Sarbia,M. (2003) The role of p63 and ΔNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis. Hum. Pathol., 34, 850-856.
95. Wang,B.Y., Gil,J., Kaufman,D., Gan,L., Kohtz,D.S. and Burstein,D.E. (2002) P63 in pulmonary epithelium, pulmonary squamous neoplasms and other pulmonary tumors. Hum. Pathol., 33, 921-926.
96. Pelosi,G., Pasini,F., Olsen Stenholm,C. et al. (2002) p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? J. Pathol., 198, 100-109.
97. Parsons,J.K., Gage,W.R., Nelson,W.G. and De Marzo,A.M. (2001) p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis. Urology, 58, 619-624.
98. Hayward,S.W., Wang,Y., Cao,M., Hom,Y.K., Zhang,B., Grossfeld,G.D., Sudilovsky,D. and Cunha,G.R. (2001) Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res., 61, 8135-8142.
99. Weinstein,M.H., Signoretti,S. and Loda,M. (2002) Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Mod. Pathol., 15, 1302-1308.
100. Iczkowski,K.A., Ferguson,K.L., Grier,D.D., Hossain,D., Banerjee,S.S., McNeal,J.E. and Bostwick,D.G. (2003) Adenoid cystic/basal cell carcinoma of the prostate: clinicopathologic findings in 19 cases. Am. J. Surg. Pathol., 27, 1523-1529.
101. Leav,I., McNeal,J.E., Ho,S.M. and Jiang,Z. (2003) Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone. Hum. Pathol., 34, 228-233.
102. Davis,L.D., Zhang,W., Merseburger,A., Young,D., Xu,L., Rhim,J.S., Moul,J.W., Srivastava,S. and Sesterhenn,I.A. (2002) p63 expression profile in normal and malignant prostate epithelial cells. Anticancer Res., 22, 3819-3825.